Skip to main content
. 2021 Jun 9;2021:9970240. doi: 10.1155/2021/9970240

Figure 2.

Figure 2

(a) The body weight. (b) Effect of berberine on CMDI. (c) Pathological changes of colon (compared with normal control group, P < 0.05 and ∗∗P < 0.01; compared with model group, #P < 0.0 and ##P < 0.01; H&E staining, x100; A, normal group; B, model group; and C, berberine group).